Wolters Kluwer expands commitment to open science

Rhea-AI Summary

Wolters Kluwer, Health announced enhancements to its Lippincott® portfolio, introducing Lippincott Preprints and the Lippincott Data Repository. These platforms facilitate the rapid sharing of medical research and clinical data, responding to the increased demand for transparency and accessibility within the medical community. Lippincott Preprints allows researchers to share findings before peer review, while the Data Repository supports the sharing of research data, improving the validation process. This move aligns with the growing need for open access medicine and aims to enhance the quality and pace of scientific communication.

Positive

• Launch of Lippincott Preprints for rapid sharing of clinical research insights.
• Introduction of Lippincott Data Repository promotes transparency by enabling data sharing.
• Enhancements support the needs of the medical community for open access and accountability.

Negative

• None.

Lippincott preprint server and data repository expand the reach and impact of breakthrough medical research

WALTHAM, Mass.--(BUSINESS WIRE)-- To support the evolution of medical publishing toward higher velocity exchange of scientific findings, Wolters Kluwer, Health announced two key additions to the Lippincott® portfolio. The Lippincott Preprints, powered by Figshare, serves as a forum for sharing pre-review medical findings with the global medical community and the Lippincott Data Repository enables researchers to share data from their clinical experiments for greater transparency and deeper validation of findings.

“For years, the medical community has called for technology to help transform medical publishing, but the pandemic really highlighted the urgency to have tools available that support this transformation in an accountable way,” said Jennifer Brogan, Vice President of Global Journal Publishing & Society Solutions, Health Learning, Research & Practice, at Wolters Kluwer. “Together, the Lippincott Preprints and Data Repository add capabilities to our publishing ecosystem that help ensure the medical research community can simultaneously count on us to increase the breadth and pace of new findings while better managing quality and authenticity.”

Powering open access medicine
With the Lippincott Preprints, authors share insights into the latest clinical research in the form of manuscripts and/or supporting data in advance of a protracted peer-review process. Using the preprint server, authors immediately disseminate their research in an open access setting, helping them meet the stringent requirements of funders and increase the accessibility of their findings.

Increasing transparency with open data
In addition to offering alternative publishing options for research, Wolters Kluwer is providing authors with the option to easily share the body of data supporting their findings. Authors submitting research to Lippincott journals can also supply data to the Data Repository through an integrated and seamless submission process. This open data capability directly addresses the data availability needs and mandated requirements of every author, ultimately increasing transparency and accountability.

“We’re honored to power the important efforts of a leading publisher by facilitating the open sharing of a wide range of data outputs and collections,” said Mark Hahnel, founder and CEO of Figshare. “The global pandemic has shown that the rapid dissemination of quality science has a critical role to play in protecting millions of lives.”

Learn more about the new enhancements to Lippincott.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220719005831/en/

Media

André Rebelo

Global Public Relations Associate Director

Wolters Kluwer

+1 (781) 392-2411

andre.rebelo@wolterskluwer.com

Source: Wolters Kluwer Health

FAQ

What are the new features introduced by Wolters Kluwer for Lippincott on date?

Wolters Kluwer launched Lippincott Preprints and Lippincott Data Repository.

How does Lippincott Preprints improve medical research sharing?

It allows researchers to share findings ahead of peer review, increasing accessibility.

What does the Lippincott Data Repository offer for researchers?

It enables authors to share clinical data, enhancing transparency and validation of findings.

What impact do these new features have on open access medicine?

They support quicker dissemination of research, improving communication in the medical field.

What is the goal of introducing these new platforms by Wolters Kluwer?

To facilitate the open sharing of medical research data and findings to enhance quality and transparency.